Pharmaceutical composition comprising an Enhancer of the secretion of insulin and Inhibitors of HMG CoA reductase inhibitors - angiotensin converting Enzyme (ACE)

摘要

Refers to a Pharmaceutical composition comprising: a) a potentiating insulin secretion as chlorpropamide, tolbutamide, Glibenclamide glicopiramida acetohexamide, tolazamide,,,Glimepiride, nateglinide, among others, and (b) inhibitors of HMG CoA reductase selected - atorvastatin, cerivastatin, lovastatin, fluvastatin,Pitavastatin or inhibitors of angiotensin converting Enzyme (ACE) selected alacepril, benazepril, captopril, enalapril, ramipril, delapril, quinapril, among others.The composition is useful for the treatment of hyperglycemia, hyperlipidemia, hyperinsulinemia, insulin resistance, retinopathy